CFH Prepares Response to draft FDA Guidance on "CAM Products and Their Regulation"

April 13, 2007 - As many of our supporters know, the FDA has issued a draft Guidance titled "Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration". The FDA's stated purpose for this Guidance is to set forth "the FDA's current thinking on this topic". The full text of the Guidance can be read at www.fda.gov/cber/gdlns/altmed.pdf. (Adobe Acrobat required).

The Board of Citizens for Health (CFH) is giving this Guidance great attention. The Board believes that the FDA's draft Guidance does not yet reflect a full understanding of the important issues involved. Furthermore, the FDA must have constructive input in order to have a legal and constructive relationship with the products and services provided and used by CFH's constituency. As a result, the CFH Board will file official comments with the FDA by the new extended May 29th deadline. Our response will be simultaneously submitted to the FDA and posted on this website.

Those wishing to make comments of their own may do so directly to the FDA. Submit written comments to:

Division of Dockets Management (HFA-305)

Food and Drug Administration

5630 Fishers Ln, Room 1061

Rockville, MD 20853

Submit emailed comments by clicking here.

Refer to Docket No. 2006D-0480 regardless of the way you choose to send your comments. You may also email the CFH Board at board@citizens.org.